"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 14 | 14 |
| 1997 | 0 | 22 | 22 |
| 1998 | 0 | 18 | 18 |
| 1999 | 0 | 8 | 8 |
| 2000 | 0 | 23 | 23 |
| 2001 | 0 | 30 | 30 |
| 2002 | 0 | 34 | 34 |
| 2003 | 0 | 30 | 30 |
| 2004 | 0 | 34 | 34 |
| 2005 | 0 | 37 | 37 |
| 2006 | 0 | 27 | 27 |
| 2007 | 0 | 55 | 55 |
| 2008 | 0 | 58 | 58 |
| 2009 | 0 | 64 | 64 |
| 2010 | 0 | 66 | 66 |
| 2011 | 0 | 74 | 74 |
| 2012 | 0 | 83 | 83 |
| 2013 | 0 | 79 | 79 |
| 2014 | 0 | 71 | 71 |
| 2015 | 0 | 69 | 69 |
| 2016 | 0 | 98 | 98 |
| 2017 | 0 | 102 | 102 |
| 2018 | 0 | 91 | 91 |
| 2019 | 0 | 111 | 111 |
| 2020 | 0 | 93 | 93 |
| 2021 | 0 | 62 | 62 |
| 2022 | 0 | 16 | 16 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 42 | 42 |
| 2025 | 0 | 44 | 44 |
| 2026 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2026 Mar 01; 152(3):313-322.
-
Evaluating Vulnerable Elders Survey-13 and FIL Geriatric Assessment in Older Adults With Aggressive Lymphomas. J Natl Compr Canc Netw. 2026 Feb; 24(2).
-
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. J Immunother Cancer. 2026 Jan 14; 14(1).
-
Comparing ASHP and PQA Frameworks for Identifying Medication Therapy Problems in Older Adults with COPD Discharged to Home Health Care: A Cross-Sectional Study. Sr Care Pharm. 2026 Jan 01; 41(1):34-42.
-
Middle Meningeal Artery Embolization for Subdural Hematoma: CT/MRI End Points of the EMBOLISE Trial. Radiology. 2026 Jan; 318(1):e251746.
-
Impact of electronic patient-reported outcomes (ePRO) presentation in pancreatic cancer tumor board discussions on cancer outcomes: the INSPIRE intervention. BMC Cancer. 2025 Dec 30; 26(1):182.
-
Early gastrostomy is associated with more efficient healthcare resource utilization in nontraumatic intracerebral hemorrhage patients. J Stroke Cerebrovasc Dis. 2026 Feb; 35(2):108536.
-
Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers. J Immunother Cancer. 2025 Dec 21; 13(12).
-
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026). J Clin Oncol. 2026 Jan 20; 44(3):153-163.
-
Major Complications following Strabismus Surgery: Nine-year Data from the IRIS? Registry. Ophthalmology. 2026 Apr; 133(4):495-498.